![]() ![]() ![]() All Clario remote data collection technologies are designed from the patient perspective because study participants, rather than trained clinicians, will be responsible for collecting the critical endpoint data that influences the conclusions of the trial. And, as we look forward, the demand for hybrid trials is only increasing with the demand for greater efficiency in clinical trial operations."Ĭlario DCT technologies span the company's solution categories including eCOA, Medical Imaging, Cardiac Safety, Respiratory and Precision Motion, giving customers a full range of options from a single provider, potentially reducing the number of technology vendors involved with their studies. "Since then, we have continued to develop and provide a variety of solutions for secure, remote data collection, so we were well positioned to help our customers from the very onset of the pandemic, minimizing disruption to patients' lives and maximizing trial continuity. We saw that patients and sponsors needed more flexibility and released our first technology for remote data collection," explained Terry Burke, Executive Vice President, eCOA at Clario. "Clario recognized 20 years ago that there was a need to develop tools and technology to enable data collection for clinical trials outside the clinical setting. Clario remote data collection technologies have been leveraged by over 2.6 million study participants in more than 4000 clinical trials to test over 1000 compounds across multiple therapeutic areas and geographies in the nearly 20 years the company has been providing these solutions.Ĭlario - The best of ERT and Bioclinica (PRNewsfoto/Clario) (PRNewswire) 2, 2022 /PRNewswire/ - Clario, a healthcare technology company that delivers the leading endpoint solutions for decentralized (DCT), hybrid and site-based clinical trials, today announced the release of new data that confirms its leadership as a provider of remote data collection technologies that enable decentralized and hybrid clinical trials. Data privacy and quality: Clario's decades of technological and scientific expertise drive trust.Nearly 20 years: Amount of time Clario has been providing remote data collection technologies.More than 4000 clinical trials: Number of studies that have leveraged Clario DCT/hybrid technologies.Over 2.6 million patients: Number of participants in Clario DCTs.More than 1000 compounds: Number of potential medicines tested using Clario remote data collection technologies.New data shows Clario has helped more than 2.6 million patients participate in life changing clinical trials for innovative new medicines through decentralized and hybrid technology solutions ![]()
0 Comments
Leave a Reply. |